Brett Newswanger

Brett Newswanger

Company: ClostraBio, Inc.

Job title: Chief Operating Officer

Seminars:

Developing Microbiome Modulating Therapeutics for Food Allergy & Colitis 3:00 pm

Novel biopolymers for targeted delivery of microbial metabolites to treat allergic and inflammatory disease Synbiotic approaches to early life disease preventionRead more

day: Day Two

Panel Discussion: Overcoming the Barrier of Securing Funding to Skyrocket Pre-Clinical & Clinical Studies 9:45 am

Challenges in securing funding for start ups Understanding the key qualifications to secure funding Tackling funding challenges for different phases of research and trials Drawbacks in funding due to low/no support from government policiesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.